Evidence map›Paper›PMID 38229935›Full record

ArticleWorld journal of methodology2023

Urine exosome mRNA-based test for monitoring kidney allograft rejection: Effects of sample transportation and storage, and interference substances.

Matt McFaul, Chris Ventura, Sean Evans, Halil Dundar, Marc J Rumpler, Christopher McCloskey, Dave Lowe, Alexandre V Vlassov

Open access · diamondAbstract read
In one paragraph

Article in World journal of methodology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Matt McFaulDepartment of Research and Development, Thermo Fisher Scientific, West Hills, CA 91304, United States.
Chris VenturaDepartment of Research and Development, Thermo Fisher Scientific, West Hills, CA 91304, United States.
Sean EvansDepartment of Research and Development, Thermo Fisher Scientific, West Hills, CA 91304, United States.
Halil DundarDepartment of Research and Development, Thermo Fisher Scientific, West Hills, CA 91304, United States.
Marc J RumplerDepartment of Research and Development, Thermo Fisher Scientific, West Hills, CA 91304, United States.
Christopher McCloskeyDepartment of Research and Development, Thermo Fisher Scientific, West Hills, CA 91304, United States.
Dave LoweDepartment of Research and Development, Thermo Fisher Scientific, West Hills, CA 91304, United States.
Alexandre V VlassovDepartment of Research and Development, Thermo Fisher Scientific, West Hills, CA 91304, United States. sasha.vlassov@thermofisher.com.
Thermo Fisher Scientific (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExosomes are 30-150 nm nanovesicles with sophisticated nucleic acids cargo, actively secreted by all cells within human body, and found in abundance in all body fluids, including urine. These extracellular vesicles have tremendous potential for next generation diagnostics, theoretically enabling noninvasive assessment of organ and tissue function

aimRecently, feasibility of an exosomal molecular test was demonstrated for post-organ transplant monitoring: Analysis of urine-derived exosomal mRNA cargo allowed early detection of kidney allograft rejection. Here, we further studied urine-derived exosomes and their mRNA content as a highly promising diagnostic modality. This included stability studies of urine samples and exosomal mRNA upon transportation from the point of collection to a centralized testing facility, short-term storage of urine at different conditions upon receipt till the point molecular assay is performed, and effects of various potentially interfering substances on the downstream quantitative polymerase chain reaction (qPCR) assay.

methodsThe urine specimens were stored at various conditions and pre-processed in different ways. Next, samples were passed through the columns to capture all extracellular vesicles, the vesicles were lysed to release their content and the exosomal RNA was purified on the mini-columns, reverse transcription was performed, next pre-amplification, followed by a qPCR analysis for a panel of mRNA markers.

resultsTo ensure exosomal RNA integrity, the harvested urine specimens should be shipped refrigerated, by overnight delivery. Urine can next be stored at the test site for up to 1 wk at 4 °C, and long term should be frozen at -80 °C. Urine specimens must be centrifuge at low G-force to deplete cells and debris, to ensure consistent top results in downstream molecular assays. All commonly used medications (tacrolimus, cyclosporin A, mycophenolic acid, everolimus, sirolimus, ascomycin, teriflunomide) were tested and confirmed that they do not cause assay interference.

conclusionmRNA from urine-derived exosomes was shown to be stable across a broad range of conditions and produced accurate results when analyzed

Indexed as

ExosomeKidney allograftLiquid biopsymRNAPost-transplant monitoringQuantitative polymerase chain reaction

Identifiers

PMID38229935
PMCPMC10789111
OpenAlexW4389965873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.